New Leaders within UM

University of Maryland School of Medicine Dean E. Albert Reece, M.D., Ph.D., M.B.A., has appointed Anthony F. Lehman, M.D., M.S.P.H., as the new senior associate dean for clinical affairs. In this new role, Dr. Lehman — professor and chair of the department of psychiatry — works closely with the University of Maryland Medical Center, the University of Maryland Medical System, the Baltimore VA Medical Center and the medical school’s faculty practice. Initially, he will continue serving as professor and chair of psychiatry, pending a national  search for a new psychiatry chair.

In his new position, Dr. Lehman will lead the School of Medicine’s clinical initiatives and develop strategies for the clinical mission for both inpatient and outpatient services. He will explore new program developments and work to create new initiatives to enhance the School of Medicine’s clinical affairs effort. He will closely collaborate with partners to strengthen clinical care within the entire medical enterprise.

Dr. Lehman joined the University of Maryland School of Medicine as an associate professor of psychiatry in 1986 and became a professor of psychiatry in 1994. He was named acting chair of the department of psychiatry in 1998 and chair in 2000.

Dr. Lehman replaces Frank M. Calia, M.D., M.A.C.P., who retired after 42 years at the School of Medicine. 

John A. Olson, Jr., M.D., Ph.D., has been appointed the new head of the division of general and oncologic surgery within the University of Maryland Medical Center’s department of surgery. Dr. Olson is also the Campbell and Jeanette Plugge Professor and vice chair of the department of surgery in the University of Maryland School of Medicine.

Dr. Olson is a nationally respected surgeon-scientist who specializes in endocrine and oncologic surgery with an emphasis on cancer of the parathyroid glands, thyroid and breast. His NIH-funded laboratory focuses on parathyroid disease, and he recently was awarded a NIH R01 grant to study molecular mechanisms of altered calcium sensing in human parathyroid disease. His clinical research interests include development of biomarkers for breast cancer and the study of aromatase inhibitor therapy to improve surgical outcomes for post-menopausal women with breast cancer. 

Dr. Olson will continue to lead progressive research initiatives to address endocrine tumors and breast cancer in his new role. Dr. Olson joins the University of Maryland from Duke University Medical Center, where he was chief of the section of endocrine, breast and oncologic surgery. He received his M.D. and Ph.D. in pharmacology and experimental therapeutics from the University of Florida. He received his general surgery training at Washington University in St. Louis and completed a surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center in New York. 

Appointments with Dr. Olson may be scheduled at 410-328-1147. His academic office can be reached at 410-328-6187. Dr. Olson’s cell phone is 919-812-6148. 

Patricia Shearer, M.D., is the new division head of pediatric hematology/oncology at the University of Maryland Children’s Hospital and professor of pediatrics at the University of Maryland School of Medicine. Dr. Shearer came to Baltimore from the University of Florida, Gainesville, where she was a faculty member and served as the director of the Cancer Survivor Program for Survivors of Childhood, Adolescent, and Adult Malignancies at the University of Florida Shands Cancer Center. Right now, Dr. Shearer is developing a cancer survivorship program at the University of Maryland. With 80% of children expected to survive cancer, this program provides clinical care, education and research for pediatric and young adult survivors in accordance with evidence-based guidelines. It monitors late effects of cancer, such as vital organ function and hormonal issues, while keeping up with emotional and academic progress of young survivors.

Dr. Shearer received her medical degree from Louisiana State University School of Medicine. She completed her pediatric residency at Johns Hopkins and a fellowship at St. Jude Children’s Research Hospital in Memphis. She has published extensively on late effects of a variety of pediatric solid tumors, including Wilms tumor, thyroid carcinoma and acute myeloid leukemia. Her clinical interests include: sarcoma, germ cell tumors and neuroblastoma, as well as Wilms tumor.

To be in touch with Dr. Shearer or to schedule an appointment, please call 410-328-2808.

This page was last updated: November 7, 2013

         
Average rating (0)